Pricing
Cyanvac
Contact
No bio yet
Samuel Wu
Chief Business Officer
This person is not in any teams
This person is not in any offices
Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Industries
Headquarters
Links
Bonsai Robotics
Vistaar Financial Services
Kinsale Capital Group
Ace Turtle
Cambridge Medical and Rehabilitation Center
View more